Alzheimer’s diagnosis is a very tiring process for both the patient and their relatives. Despite intensive research, the cure for Alzheimer’s has not yet been found; however, progress has been made in the fight against the disease. The quality of life and the right to self-determination of those affected by this disease should be preserved for as long as possible. Drug treatments in Alzheimer’s disease provide a very limited benefit in the progression of the disease. Transcranial Pulse Stimulation (TPS) – NEUROLITH as a revolutionary new treatment for Alzheimer’s Disease developed by the University of Wienna, Austria – University of Toronto in Canada and STORZ MEDICAL AG SWITZERLAND is the ONLY EFFECTIVE, SAFE, NON-INVASIVE treatment method approved the treatment of Alzheimer’s patients.
NeuroUp treatment protocol with Transcranial Pulse Stimulation TPS will be implemented for the first time in our country at NeuroUpclinic almost simultaneously with centers in developed countries around the world. The current treatment is currently used in Austria, Switzerland, Germany, England, Canada, Hongkong, Spain, Portugal, France and Denmark.
The TPS neural stimulation technique, developed by an international consortium led by Vienna, is the only technique that can activate deep regions of the brain in a targeted and non-invasive manner. Therefore, all diseases such as Parkinson’s, MS, Stroke, Neuralgia, in which it is still possible to restore impaired brain functions by activating functional neurons, are candidates for the new Transcranial Pulse Stimulation (TPS) treatment. Transcranial Pulse Stimulation (TPS) is already licensed for the treatment of Alzheimer’s. (CE Certificate)